← Back
$MYGN All transactions

MYRIAD GENETICS INC

F

$ Value

$169K

Shares

36,304

Price

$5

Filed

Mar 16

Insider

Name

Raha Samraat S.

Title

President and CEO

CIK

0001738340

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-13

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,075,357

Footnotes

Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. | Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Filing Info

Accession No.

0001738340-26-000004

Form Type

4

Issuer CIK

0000899923

Raha Samraat S.'s History

Date Ticker Type Value
2026-03-14 MYGN F $50K
2026-03-13 MYGN F $169K
2026-03-12 MYGN A $0
2026-03-09 MYGN $200K
2025-12-11 MYGN F $216K
2025-05-31 MYGN A $5K
2025-04-30 MYGN A $0

Other Insiders at MYGN (90d)

Insider Bought Sold Last
Phanstiel S. Louise $495K 2026-02-27
Raha Samraat S.
President and CEO
$200K 2026-03-14
Solaiman Shereen
Chief People Officer
2026-03-14
Verratti Mark
Chief Operating Officer
2026-04-14
Haas Kevin Richard
Chief Technology Officer
2026-03-15
Fox Jennifer Lynne
Chief Legal Officer
2026-03-13
Muzzey Dale
Chief Scientific Officer
2026-04-14
Donnelly Brian J
Chief Commerical Officer
2026-03-12
Wheeler Benjamin Richard
Chief Financial Officer
2026-03-22